Private Capital Management (Minnesota)’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,000	Closed	-$80K	–	165
2017 Q2	$80K	Buy	+5,000	New	+$80K	0.09%	165